Top Gainers Losers Drive Friday Action

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  26 Sep 2025
 

•   CDLX  
   
  0.00%
•   CNXC  
   
  0.00%
•   CPOP  
   
  0.00%
•   CRNX  
   
  0.00%
•   LPTH  
   
  0.00%

$NUAI continues its impressive seven-day winning streak, surging 33.33% to $1.84 on massive volume of 150.72 million shares, nearly seven times its average daily volume of 21.97 million. This artificial intelligence play has clearly caught momentum traders' attention, though the lack of specific catalysts suggests this could be pure technical momentum or speculation around AI sector rotation.

$CRNX dominated headlines with a spectacular 27.92% rally to $45.91 following the FDA's approval of PALSONIFY (paltusotine) as a first-line treatment for acromegaly, a rare growth disorder. This represents a major milestone for Crinetics Pharmaceuticals, as PALSONIFY becomes the first daily pill option for patients with this condition. The approval triggered a surge in volume to 9.50 million shares versus the typical 1.22 million daily average. Cantor Fitzgerald reiterated its Overweight rating, suggesting analysts remain bullish despite the recent run-up.

$PRLD has quietly built momentum over five consecutive trading sessions, gaining 22.95% today to reach $1.50 on volume of 721,320 shares compared to its 209,250 average. The sustained buying interest without major news suggests either insider accumulation or technical breakout momentum that's attracting algorithmic trading systems.

$LPTH jumped 21.54% to $7.90 following mixed fourth-quarter results that somehow managed to impress analysts despite missing earnings expectations. LightPath Technologies reported a quarterly loss of 16 cents per share, wider than anticipated, yet analysts have raised their forecasts following the results. The 4.74 million share volume, nearly three times normal—indicates institutions may be repositioning based on forward guidance rather than backward-looking earnings metrics.

$CDLX gained 18.49% to $2.82 as the blockchain mining company capitalized on renewed cryptocurrency optimism. The stock climbed an additional 5.2% in after-hours trading to $12.24, suggesting momentum could continue into Monday's session. With Bitcoin showing strength, miners like Cipher are benefiting from both operational leverage and speculative flows.

On the downside, $CNXC suffered a brutal 13.33% decline to $47.66 despite posting earnings growth and raising its dividend by 8.2% to $0.36. The market's focus appears centered on margin recovery concerns and potential tariff impacts, overshadowing the company's positive operational metrics. Volume surged to 5.36 million shares versus its typical 701,000, indicating heavy institutional selling pressure.

$SNGX plummeted 25.93% to $1.20 following the pricing of a $7.5 million public offering at $1.35 per share. Soligenix's dilutive equity raise spooked investors despite the company's late-stage biopharmaceutical pipeline. The seven-day losing streak preceding today's news suggests investors were already positioning defensively ahead of the capital raise announcement.

$PEPG experienced whiplash volatility, initially soaring 121% on stellar experimental treatment trial results before giving back 13.78% to close at $5.07. This classic biotech pattern of "buy the rumor, sell the news" played out in real-time as profit-taking overwhelmed the initial euphoria. The 5.97 million share volume suggests significant institutional repositioning occurred throughout the session.

$CPOP crashed 55.13% to $0.92 following the announcement of a 5 million share registered direct offering. Pop Culture Group's massive dilution sent existing shareholders running for the exits, with volume spiking to 5.02 million shares compared to its 2.94 million average.

View All Headlines